Jul 26, 2013, 05.03 PM IST
Sharmila Joshi, Head of Equity of Peerless Securities recommends holding Biocon with a target of around Rs 340.
Sharmila Joshi, Head of Equity of Peerless Securities told CNBC-TV18, " Biocon is a hold at this price. It has been a very steady performer with a very good sustained kind of a growth from the stock. So, one will see some amount of buying coming on even on account of that. I will give it a target of about Rs 340 given the next year kind of an horizon."
He further added, "I think pharma like FMCG is going to be a space which investors will want to keep having in volatile markets such as now. So, I think even from that perspective Biocon becomes a good hold."
Action in Biocon
Video of the day
Dec 13 2013, 10:39
- in MARKET OUTLOOK
Dec 4 2013, 11:08
- in FII View
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.